Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioceres Crop Solutions (BIOX) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Bioceres Crop Solutions (BIOX) over the last 9 years, with Q3 2025 value amounting to -$12.6 million.

  • Bioceres Crop Solutions' Non Operating Income fell 2857.14% to -$12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$36.5 million, marking a year-over-year decrease of 2897.53%. This contributed to the annual value of -$14.1 million for FY2025, which is 138.31% up from last year.
  • Latest data reveals that Bioceres Crop Solutions reported Non Operating Income of -$12.6 million as of Q3 2025, which was down 2857.14% from -$26.2 million recorded in Q2 2025.
  • Bioceres Crop Solutions' 5-year Non Operating Income high stood at $12.7 million for Q1 2021, and its period low was -$26.2 million during Q2 2025.
  • Its 5-year average for Non Operating Income is -$4.3 million, with a median of -$7.5 million in 2023.
  • In the last 5 years, Bioceres Crop Solutions' Non Operating Income crashed by 22163.05% in 2022 and then soared by 15789.47% in 2024.
  • Over the past 5 years, Bioceres Crop Solutions' Non Operating Income (Quarter) stood at $8.2 million in 2021, then tumbled by 221.63% to -$10.0 million in 2022, then rose by 27.0% to -$7.3 million in 2023, then decreased by 2.74% to -$7.5 million in 2024, then tumbled by 68.0% to -$12.6 million in 2025.
  • Its Non Operating Income stands at -$12.6 million for Q3 2025, versus -$26.2 million for Q2 2025 and $9.8 million for Q1 2025.